Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the White House. Late last month, President Donald Trump stated on Truth Social that pregnant women shouldn't use Tylenol unless absolutely necessary. With…

Benzinga

AngioDynamics Eyes Growth Despite Tariffs

AngioDynamics, Inc. (NASDAQ:ANGO) posted stronger-than-expected first-quarter results across its Med-Tech businesses and lifted its fiscal 2026 guidance.

Benzinga

Teladoc (TDOC) Shares Climb On Bullish Commentary From Citron Research

Shares of Teladoc Health Inc (NYSE:TDOC) are surging Friday morning after Citron Research posted bullish comments on the telehealth provider, asserting they were “not wrong, just early” on the stock’s potential. The commentary sparked renewed investor interest, pushing the stock higher in early trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Anti-abortion groups furious as FDA approves generic abortion pill

Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval

The Guardian - US

The Best Biotech ETFs to Buy

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Kiplinger

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap

Health care stocks are on track for their best week in years, yet even after the rally, several pharma giants remain absurdly cheap by market standards.

Benzinga

Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket

Shares of Concorde International Group Ltd. (NASDAQ:CIGL) rose sharply in pre-market trading as the company revealed that its Board of Directors and Compensation Committee had approved a 2025 Equity Incentive Plan earlier that day.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide surge in health care stocks that delivered the biggest rally in five years.

Benzinga

Inside the TrumpRx website and its unusual launch

Trump has been urging prescription drug manufacturers to lower U.S. prices.

Axios

Moderna Stock Is Rallying Wednesday: What's Driving The Action?

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.

Benzinga

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

Benzinga

Big pharma is at war with the UK, and the government can’t back down now

The industry has always wanted the NHS to pay more for its drugs; now it is pulling research and investment out of Britain, says director of Global Justice Now Nick Dearden

The Guardian - UK

Baroness Michelle Mone-linked company loses £122m High Court battle with government over faulty PPE

Michelle Mone’s husband Douglas Barrowman branded the PPE Medpro defeat in the High Court a “whitewash”

Evening Standard

Convatec to open new R&D hub in Manchester as part of £500m UK investment

The medical products firm said the ‘flagship’ site would open in 2027.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

TrumpRx: Trump and Pfizer Announce Landmark Deal to Slash US Drug Prices by Up to 85%

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.

Caixin Global

Beijing Life Science Hub Aims to Accelerate Drug Innovation

Zhongguancun Life Science Park is fostering a full-chain ecosystem to shorten drug development cycles

International Business Times

Trump Announces Pfizer Deal He Says Will Lower Certain Drug Prices

The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant vowed to voluntarily lower the prices of unspecified drugs for US purchase.

Benzinga

Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push

On Tuesday, Pfizer Inc. (NYSE:PFE) announced a historic agreement with the Trump Administration to ensure U.S. patients pay lower prices for their prescription medicines.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

AnaptysBio Charts Path To Split Into Two Public Companies By 2026

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies.

The Guardian - US

Pfizer agrees to offer discounted drugs through new federal website, Trump announces

President also said that company would offer medications to Medicaid at ‘most favored nation’ pricing

The Independent UK

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with President Donald Trump's administration

The National (Scotland)

Michelle Mone accuses UK Government of 'scapegoating' over PPE firm

Tory peer Michelle Mone accused the UK Government of making her and her husband a 'poster couple for the PPE scandal' ...

Benzinga

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Benzinga

Pharma's Direct-To-Patient Wave Hits Novartis Next

The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine.

The Guardian - UK

Emma Walmsley steadied GSK – but doubts linger over growth targets

The outgoing chief executive reshaped the drugmaker, yet scepticism persists over promised revenues

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.